MCM
KERX

Munder Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Munder Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.97M Buy
288,800
+269,955
+1,433% +$4.13M 0.03% 324
2014
Q2 		$290K Sell
18,845
-330
-2% -$4.68K ﹤0.01% 544
2014
Q1 		$327K Sell
19,175
-825
-4% -$12.4K ﹤0.01% 545
2013
Q4 		$259K Buy
+20,000
New +$239K ﹤0.01% 548

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Munder Capital Management's KERX Position: Q3 2014 in Review

Munder Capital Management increased its Keryx Biopharmaceuticals Inc (KERX) stake by 1,433% in Q3 2014, buying an estimated $4.13M and bringing the position to 288,800 shares worth $3.97M. The position accounts for 0.03% of the portfolio, ranked #324.

Munder Capital Management first reported a position in KERX in Q4 2013 and has held it in 4 quarters since. 140 funds tracked by Wall St. Rank hold KERX as of Q3 2014.

  • Munder Capital Management held 288,800 shares of Keryx Biopharmaceuticals Inc worth $3.97M as of Q3 2014.
  • Munder Capital Management bought 269,955 Keryx Biopharmaceuticals Inc shares in Q3 2014, an estimated $4.13M.
  • Keryx Biopharmaceuticals Inc made up 0.03% of Munder Capital Management's portfolio in Q3 2014, its #324 holding.
  • Munder Capital Management first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and has held it in 4 quarters since.
  • 140 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.